Blood Culture Contamination Clinical Trial
Official title:
A Randomized Controlled Study of Blood Test Draw Order to Reduce Blood Culture Contamination
| Verified date | September 2018 |
| Source | Shaare Zedek Medical Center |
| Contact | n/a |
| Is FDA regulated | No |
| Health authority | |
| Study type | Interventional |
A randomized partially controlled study to examine the effect of blood diversion into a heparin lithium tube on the incidence of blood culture contamination.
| Status | Completed |
| Enrollment | 970 |
| Est. completion date | February 28, 2019 |
| Est. primary completion date | February 28, 2019 |
| Accepts healthy volunteers | No |
| Gender | All |
| Age group | 18 Years and older |
| Eligibility |
Inclusion Criteria: - Age > 18 - Presence in Emergency Room during extended office hours (0800-2000 on weekdays( - Clinical requirement for Blood culture and biochemistry tests from venepuncture Exclusion Criteria: - None |
| Country | Name | City | State |
|---|---|---|---|
| Israel | Shaare Zedek Medical Center | Jerusalem |
| Lead Sponsor | Collaborator |
|---|---|
| Shaare Zedek Medical Center |
Israel,
| Type | Measure | Description | Time frame | Safety issue |
|---|---|---|---|---|
| Primary | Blood culture contamination | Growth of bacteria defined as blood culture contaminants (for example coagulase negative staphylococci in one bottle only). | up to 7 days from obtaining blood culture | |
| Secondary | Patient length of stay | Length of stay from arrival at Emergency room until discharge in hours | up to 3 months from arrival |
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Not yet recruiting |
NCT05576233 -
• Comparison of Blood Culture Contamination Rates
|
N/A | |
| Completed |
NCT04573894 -
Diagnostic Performance of Plasma Procalcitonin for the Detection of Blood Cultures Contaminations
|